Resultado de búsqueda
The Galveston National Laboratory (GNL) is a sophisticated high containment research facility that serves as a critically important resource in the global fight against infectious diseases.
The Galveston National Laboratory (GNL) in Galveston, Texas, United States, is a high security National Biocontainment Laboratory housing several Biosafety level 4 research laboratories. The lab is run by the University of Texas Medical Branch (UTMB) for exotic disease diagnosis and research.
The GNL is an anchor lab of the NIAID Biodefense Laboratory Network, which includes laboratories built by NIH at 14 universities throughout the U.S. with containment capabilities for biodefense research.
The investigators at the Galveston National Laboratory (GNL) are known around the world for both their basic research and their translational discoveries related to existing and emerging infectious diseases.
Gary Kobinger, PhD, is the Director of the Galveston National Laboratory, one of the largest active biocontainment facilities on an academic campus. Dr. Kobinger has co-authored over 300 peer-reviewed scientific manuscripts and accumulated more than 20 years of experience working in or managing high-containment laboratories.
As one of two National Biocontainment Laboratories constructed under grants awarded by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the Galveston National Laboratory (GNL) enables progress in our understanding of the fundamental mechanisms underlying the spread of infectious diseases and ...
This 172,000-sf state-of-the-art biocontainment research facility provides much-needed laboratory space for researchers from around the United States and includes BSL-4 laboratories, as well as supporting BSL-3 and BSL-2 laboratories and BSL-4, BSL-3, and BSL-2 animal laboratories.
